ArticleBiomedicines2026

Integrative Multi-Omics and Pan-Cancer Analyses Identify CCL20 as a Prognostic Biomarker with Therapeutic Relevance in Esophageal Cancer.

Shixiang Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.